Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Presentation TCT 2014

Case Presentation

Presenter: Tamim Nazif

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Hemal Gada

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Philip Green

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Isaac George

September 16, 2014

Presentation TCT 2014

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Presenter: Luis Nombela-Franco

September 16, 2014

Presentation TCT 2014

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Presenter: Ran Kornowski

September 16, 2014

Presentation TCT 2014

TCT 695: Clinical Impact and Evolution of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-analysis

Presenter: John A. Bittl, Tullio Palmerini, Luis Nombela-Franco, MD

September 15, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

Presentation TCT 2013

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Presenter: Andreas R?ck

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation

Presenter: John Webb

October 27, 2013

Advertisement

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

TCT 2019 Day Two: Transcatheter Valves, New and Old

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Case Presentation

Case Presentation

Case Presentation

Case Presentation

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

TCT 695: Clinical Impact and Evolution of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-analysis

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content